Systemic Redox Biomarkers in Neurodegenerative Diseases
Journal:
Current Drug Metabolism
Volume:
16
Page:
46-70
Author(s):
Anna Pastore, Sara Petrillo, Emanuela Piermarini and Fiorella Piemonte
Genomic and Pharmacogenomic Biomarkers of Parkinson’s Disease
Journal:
Current Drug Metabolism
Volume:
15
Page:
129-181
Author(s):
Hortensia Alonso-Navarro, Felix Javier Jimenez-Jimenez, Elena Garcia-Martin and Jose A.G. Agundez
Consequences of Iron Accumulation in Microglia and its Implications in Neuropathological Conditions
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
12
Page:
785-798
Author(s):
Gurugirijha Rathnasamy, Eng-Ang Ling and Charanjit Kaur
The Journey From Metabolic Profiling to Biomarkers: The Potential of NMR Spectroscopy Based Metabolomics in Neurodegenerative Disease Research
Journal:
Current Metabolomics
Volume:
1
Page:
160-179
Author(s):
Philippine C. Geiszler, Dorothee P. Auer and Clare A. Daykin
Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA)
Journal:
Current Neuropharmacology
Volume:
11
Page:
59-79
Author(s):
Susanne A. Schneider, Petr Dusek, John Hardy, Ana Westenberger, Joseph Jankovic and Kailash P. Bhatia
Editorial (Hot Topic: Neurodegeneration with Brain Iron Accumulation)
Journal:
Current Drug Targets
Volume:
13
Page:
1181-1181
Author(s):
Hiroaki Miyajima
Pantothenate Kinase-Associated Neurodegeneration
Journal:
Current Drug Targets
Volume:
13
Page:
1182-1189
Author(s):
Monika B. Hartig, Holger Prokisch, Thomas Meitinger and Thomas Klopstock
Pantothenate Utilization by Plasmodium as a Target for Antimalarial Chemotherapy
Journal:
Infectious Disorders - Drug Targets
Volume:
10
Page:
200-216
Author(s):
C. Spry, D.A. van Schalkwyk, E. Strauss and K.J. Saliba